0000919574-22-005947.txt : 20221013 0000919574-22-005947.hdr.sgml : 20221013 20221013153951 ACCESSION NUMBER: 0000919574-22-005947 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(7) FILED AS OF DATE: 20221013 DATE AS OF CHANGE: 20221013 EFFECTIVENESS DATE: 20221013 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Sofinnova BioEquities Enhanced Master Fund, LP CENTRAL INDEX KEY: 0001949475 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-461670 FILM NUMBER: 221309068 BUSINESS ADDRESS: STREET 1: 3000 SAND HILL ROAD STREET 2: BUILDING 4, SUITE 250 CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650-681-8482 MAIL ADDRESS: STREET 1: 3000 SAND HILL ROAD STREET 2: BUILDING 4, SUITE 250 CITY: MENLO PARK STATE: CA ZIP: 94025 D 1 primary_doc.xml X0708 D LIVE 0001949475 Sofinnova BioEquities Enhanced Master Fund, LP 3000 SAND HILL ROAD BUILDING 4, SUITE 250 MENLO PARK CA CALIFORNIA 94025 650-681-8482 DELAWARE None None Limited Partnership true 2022 -- Sofinnova BioEquities GP LLC 3000 Sand Hill Road Building 4, Suite 250 Menlo Park CA CALIFORNIA 94025 Executive Officer Promoter General Partner -- Sofinnova Investments, Inc. 3000 Sand Hill Road Building 4, Suite 250 Menlo Park CA CALIFORNIA 94025 Executive Officer Promoter Investment Manager Pooled Investment Fund Hedge Fund false Decline to Disclose 06b 3C 3C.7 false 2022-10-03 true true true false 0 Indefinite 1980195 Indefinite false 2 0 true 0 true 0 true The Investment Manager receives customary management fees. false Sofinnova BioEquities Enhanced Master Fund, LP /s/Jim Brody Jim Brody Chief Compliance Officer 2022-10-13